INBX

Companies
NASDAQ
Inhibrx Inc.
Health Care
Price Chart
Overview

About INBX

development of antibodies

Market Cap
$241.0M
Volume
2.1M
Avg. Volume
1.7M
P/E Ratio
-1.0897553
Dividend Yield
0.00%
Employees
153.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Risk & Correlation Analysis
Market Correlation
0.90
Moderate Correlation
Volatility
High (0.65)
Relative to market

Macro Factor Sensitivities

Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for INBX.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, INBX shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$241.0M
Volume2.1M
P/E Ratio-1.09
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 24, 2024

PortfolioPilot Analysis

Get AI-powered insights on how INBX fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025